SNCA and Parkinson disease: Applying the system to human induced pluripotent stem cell (hiPSC)-derived dopaminergic neurons from a PD patient with the SNCA triplication resulted in downregulation of SNCA mRNA and α-Syn protein, which was mediated by targeted DNA methylation at intron 1.